These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31519431)

  • 41. How to hit the allergy target: A critical appraisal of intralymphatic immunotherapy with practical recommendations on ultrasound-guided injections.
    Flory S; Hviid-Vyff B; Šošić L; Schmid JM; Ahlbeck L; Widmer ECJ; Lang CCV; Ikenberg K; Kündig TM; Hoffmann HJ; Johansen P
    Allergy; 2024 Aug; 79(8):2222-2234. PubMed ID: 38712754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial.
    Varney VA; Tabbah K; Mavroleon G; Frew AJ
    Clin Exp Allergy; 2003 Aug; 33(8):1076-82. PubMed ID: 12911781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The efficacy and safety of standardized dust mite allergen subcutaneous immunotherapy in children with allergic rhinitis during treatment].
    Yuan X; Xie SB; Zhang H; Zhang JY; Wang FJ; Liu YZ; Meng L; Zhong W; Jiang WH; Xie ZH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Sep; 58(9):878-884. PubMed ID: 37675526
    [No Abstract]   [Full Text] [Related]  

  • 44. Intralymphatic immunotherapy for allergic rhinitis: A systematic review and meta-analysis.
    Werner MT; Bosso JV
    Allergy Asthma Proc; 2021 Jul; 42(4):283-292. PubMed ID: 34187620
    [No Abstract]   [Full Text] [Related]  

  • 45. [Compliance and safety evaluation of subcutaneous versus sublingual immunotherapy in mite-sensitized patients with allergic rhinitis].
    Zhu L; Lu JH; Xie Q; Wu YL; Zhu LP; Cheng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jun; 45(6):444-9. PubMed ID: 21055319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
    Polzehl D; Keck T; Riechelmann H
    Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis.
    Bozek A; Ignasiak B; Filipowska B; Jarzab J
    Clin Exp Allergy; 2013 Feb; 43(2):242-8. PubMed ID: 23331565
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
    Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose pollen intralymphatic immunotherapy: Two RDBPC trials question the benefit of dose increase.
    Hellkvist L; Hjalmarsson E; Weinfeld D; Dahl Å; Karlsson A; Westman M; Lundkvist K; Winqvist O; Georén SK; Westin U; Cardell LO
    Allergy; 2022 Mar; 77(3):883-896. PubMed ID: 34379802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of allergen-induced late inflammatory reactions in the nose and in the skin in house dust mite-allergic patients with or without asthma.
    Lopuhaä CE; de Riemer MJ; Out TA; Sjamsoedin DH; Aalberse RC; Jansen HM; van der Zee JS
    Int Arch Allergy Immunol; 2003 Apr; 130(4):266-74. PubMed ID: 12740527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intralymphatic immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis.
    Hoang MP; Seresirikachorn K; Chitsuthipakorn W; Snidvongs K
    Rhinology; 2021 Jun; 59(3):236-244. PubMed ID: 33647073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of long-term effect for house dust mite subcutaneous immunotherapy for patients with allergic rhinitis].
    Song W; Lin X; Chai R
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 50(8):632-5. PubMed ID: 26696199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simplified local nasal immunotherapy in mite dust allergic rhinitis.
    Bellussi L; Bologna M; Di Stanislao C; Lauriello M; Mezzedimi C; Muzi P; Passàli GC; Passàli D
    J Investig Allergol Clin Immunol; 2002; 12(1):42-7. PubMed ID: 12109531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of house dust mite sublingual immunotherapy in patients with allergic rhinitis according to duration.
    Lin Z; Liu Q; Li T; Chen D; Chen D; Xu R
    Int Forum Allergy Rhinol; 2016 Jan; 6(1):82-7. PubMed ID: 26575696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sustained effects of intralymphatic pollen-specific immunotherapy on Japanese cedar pollinosis.
    Terada T; Omura S; Kikuoka Y; Suzuki M; Inaka Y; Inui T; Matsuda M; Nabe T; Kawata R
    Rhinology; 2020 Jun; 58(3):241-247. PubMed ID: 32091032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.
    Compalati E; Passalacqua G; Bonini M; Canonica GW
    Allergy; 2009 Nov; 64(11):1570-9. PubMed ID: 19796205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive Study of Patients' Compliance with Sublingual Immunotherapy in House Dust Mite Perennial Allergic Rhinitis.
    Malet A; Azpeitia A; Gutiérrez D; Moreno F; San Miguel Moncín Mdel M; Cumplido JA; Lluch M; Baró E; Roger A
    Adv Ther; 2016 Jul; 33(7):1199-214. PubMed ID: 27312976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
    Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
    Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis.
    Wang ZX; Shi H
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):407-411. PubMed ID: 28585143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of intralymphatic immunotherapy in allergic rhinitis: A systematic review and meta-analysis.
    Aini NR; Mohd Noor N; Md Daud MK; Wise SK; Abdullah B
    Clin Transl Allergy; 2021 Aug; 11(6):e12055. PubMed ID: 34429875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.